Business Description
e-Therapeutics PLC
NAICS : 325412
ISIN : GB00B2823H99
Description
e-Therapeutics PLC is a drug discovery company. Its ambition is to transform the drug discovery process, leveraging its computational network biology platform (drug discovery) to find novel targets to address mechanisms underpinning complex disease. l company activities are carried out in the UK.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.96 | |||||
| 9-Day RSI | 37.11 | |||||
| 14-Day RSI | 38.19 | |||||
| 6-1 Month Momentum % | 0.22 | |||||
| 12-1 Month Momentum % | -7.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -3040.59 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
e-Therapeutics PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | 0.34 | ||
| EPS (TTM) (£) | -0.018 | ||
| Beta | 0 | ||
| Volatility % | 145.43 | ||
| 14-Day RSI | 38.19 | ||
| 14-Day ATR (£) | 0.012452 | ||
| 20-Day SMA (£) | 0.099775 | ||
| 12-1 Month Momentum % | -7.23 | ||
| 52-Week Range (£) | 0.08 - 0.24 | ||
| Shares Outstanding (Mil) | 584.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
e-Therapeutics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
e-Therapeutics PLC Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
e-Therapeutics PLC Frequently Asked Questions
What is e-Therapeutics PLC(LSE:ETX)'s stock price today?
The current price of LSE:ETX is £0.09. The 52 week high of LSE:ETX is £0.24 and 52 week low is £0.08.
When is next earnings date of e-Therapeutics PLC(LSE:ETX)?
The next earnings date of e-Therapeutics PLC(LSE:ETX) is 2025-05-10 Est..
Does e-Therapeutics PLC(LSE:ETX) pay dividends? If so, how much?
e-Therapeutics PLC(LSE:ETX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers